)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Glycorex Transplantation
Glycorex Transplantation (GTAB) investor relations material
Glycorex Transplantation Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary25 Feb, 2026
Executive summary
Achieved 10% year-over-year revenue growth to 38.8 MSEK, with improved operating results and reduced losses compared to 2024.
Sales increased in most markets, notably in Mexico, Switzerland, Czechia, and Singapore; Germany, the largest market, grew 10%.
Entered new markets (Portugal, Morocco) and resumed sales in Greece.
Secured a multi-year contract with a leading Dutch university hospital for GlycosorbⓇ ABO.
Published a significant pediatric heart transplantation study, recognized among the year's top five in its field.
Financial highlights
Full-year net sales: 38.8 MSEK (35.2 MSEK in 2024), up 10%.
Operating result: -7.3 MSEK (-10.4 MSEK in 2024); net result: -7.7 MSEK (-10.9 MSEK in 2024).
Q4 net sales: 9.4 MSEK (10.5 MSEK in Q4 2024); Q4 net result: -2.7 MSEK (-2.0 MSEK in Q4 2024).
Cash flow for the year: 4.5 MSEK (-7.0 MSEK in 2024); cash and equivalents at year-end: 10.2 MSEK (5.8 MSEK in 2024).
No dividend proposed for 2025.
Outlook and guidance
Entering 2026 with confidence, driven by ongoing projects and strengthened regulatory foundation.
Focus on expanding in growth markets (India, Mexico, South Africa) and launching new products, especially for rheumatoid arthritis.
Continued investment in research and development, with a study for RA patients planned.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Glycorex Transplantation
- Q3 2025 saw 29% sales growth, improved margins, and new clinical and market breakthroughs.GTAB
Q3 202528 Nov 2025 - Sales up 11% in Q2 2025, losses halved, and liquidity strengthened by new share issue.GTABQ2 202529 Aug 2025
- Double-digit sales growth and improved results, with strategic expansion in key markets.GTABQ3 202413 Jun 2025
- Sales growth and improved results, but cash flow and liquidity risks persist.GTABQ2 202413 Jun 2025
- Double-digit sales growth and narrowed losses position Glycorex for global expansion.GTABQ4 20249 Jun 2025
- Strong sales growth and improved earnings, with expanded market presence and liquidity.GTABQ1 20256 Jun 2025
Next Glycorex Transplantation earnings date
Q1 202622 May, 2026
Glycorex Transplantation
Next Glycorex Transplantation earnings date
Q1 202622 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage